First, NAFLD and NASH occur most commonly in individuals with obesity, particularly abdominal or visceral obesity; these individuals are known, on average, to have relative reductions in GH secretion [9,10]. The gene discussed is GH1; the disease is metabolic dysfunction-associated steatotic liver disease.